Takundwa, Mutsa MThimiri Govindaraj, Deepak B2024-11-252024-11-2520241877-11731878-0814https://doi.org/10.1016/bs.pmbts.2024.03.021http://hdl.handle.net/10204/13849Synthetic biology, precision medicine, and nanobiotechnology are the three main emerging areas that drive translational innovation toward commercialization. There are several strategies used in precision medicine and drug repurposing is one of the key approaches as it addresses the challenges in drug discovery (high cost and time). Here, we provide a perspective on various new approaches to drug repurposing for cancer precision medicine. We report here our optimized wound healing methodology that can be used to validate drug sensitivity and drug repurposing. Using HeLa as our benchmark, we demonstrated that the assay can be applied to identify drugs that limit cell proliferation. From a future perspective, this assay can be expanded to ex vivo culturing of solid tumors in 2D culture and leukemia in 3D culture.AbstractenSynthetic biologyPrecision medicineNanobiotechnologyDrug discoveryArticlen/a